SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-19-000054
Filing Date
2019-01-10
Accepted
2019-01-10 16:16:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO THE SCHEDULE 13D sc13da409455028_01102019.htm SC 13D/A 208422
  Complete submission text file 0000921895-19-000054.txt   209951
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Subject) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87524 | Film No.: 19520409
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 610 NEWPORT CENTER DRIVE SUITE 250 NEWPORT BEACH CA 92660
Business Address 610 NEWPORT CENTER DRIVE SUITE 250 NEWPORT BEACH CA 92660 949-734-7900
Engaged Capital LLC (Filed by) CIK: 0001559771 (see all company filings)

IRS No.: 454591052 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A